methylformamide has been researched along with Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arancia, G; Calcabrini, A; Citro, G; Molinari, A; Verdina, A; Villa, AM; Zupi, G | 1 |
| Bajorin, DF; Casper, ES; Eton, O; Houghton, AN | 1 |
| Eisenhauer, EA; Kerr, I; Quirt, I; Weinerman, BH | 1 |
1 trial(s) available for methylformamide and Melanoma
| Article | Year |
|---|---|
Phase II trial of N-methylformamide in patients with metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Formamides; Humans; Infusions, Intravenous; Liver; Male; Melanoma; Middle Aged; Phosphates | 1991 |
2 other study(ies) available for methylformamide and Melanoma
| Article | Year |
|---|---|
Effects of sequential combinations of N-methylformamide with adriamycin on cultured melanoma cells (M14).
Topics: Antineoplastic Agents; Doxorubicin; Drug Administration Schedule; Fluorescent Antibody Technique; Formamides; Humans; Melanoma; Microscopy, Electron, Scanning Transmission; Tumor Cells, Cultured | 1994 |
Toxicity of oral N-methylformamide in three phase II trials: a report from the National Cancer Institute of Canada Clinical Trials Group.
Topics: Alkaline Phosphatase; Antineoplastic Agents; Aspartate Aminotransferases; Bilirubin; Canada; Chemical and Drug Induced Liver Injury; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Formamides; Glioma; Humans; Male; Melanoma; Nausea; Rectal Neoplasms | 1986 |